Microbiology
Showing page 197 of 255 pages of list content
-
The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN
This article's authors -
Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro
This article's authors -
A comprehensive transcriptome analysis reveals broader but weaker host response of SARS-CoV-2 than SARS-CoV
This article's authors -
Insights into Cross-species Evolution of Novel Human Coronavirus SARS-CoV-2 and Defining Immune Determinants for Vaccine Development
This article's authors -
Identification of four linear B-cell epitopes on the SARS-CoV-2 spike protein able to elicit neutralizing antibodies
This article's authors -
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
This article's authors -
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
This article's authors -
Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India
This article's authors -
In vitro infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic response
This article's authors -
Potential Achilles heels of SARS-CoV-2 are best displayed by the base order-dependent component of RNA folding energy
This article's authors